Synthesit was presented at the Scientific and Practical Conference on "Age Associated Diseases and Active Longevity" held on 12/22/2022.
The conference was supported by the Research Institute of Health Care Organization and Medical Management of the Department of Health Care of Moscow, the Russian Professors' Assembly, the Commission of the Russian Federation for UNESCO - Bioethics Committee and the International Fund for the Development of Biomedical Technologies by V.P. Filatov.
The patients who have been taking Synthesit since 2019 note it helps them maintain normal blood pressure, and in some cases, reduce the dose or completely withdraw from conventional hypotensive drugs. All the changes in medication regimen were under the supervision of attending physicians. This is related to the key features of high blood pressure such as damaged arteries and the restriction of blood flow to the heart and other organs and tissues of the body.
Within the conference Olga Oinotkinova ( M.D., Professor of the Department of Internal Disease and Preventive Medicine, Central State Medical Academy of the Presidential Administration of the Russian Federation, Honored Physician of the Russian Federation, scientific director of the school of lipidology and associated metabolic diseases, president of the National Society for the Study of Lipidology and Associated Metabolic Diseases) made a report on the action of Synthesit, in which she highlighted the unique natural properties of biologically active nutraceutical Synthesit, which are due to its high quality and the content of such important components for the human body as special iron and its metabolites that improve the delivery and saturation of organs and tissues with oxygen, thereby improving the flow properties of blood by normalizing the function of red blood cells and platelets, improving microcirculation, as well as hemodynamic parameters such as heart rate.
An important property of Synthesit is its ability to improve lipid metabolism, reducing cholesterol and its atherogenic fraction, low-density lipoprotein. Along with the normalization of liver enzymes AST and ALT, increasing the enzymes of antioxidant protection of organs and tissues from external negative influences.
The results of preclinical studies allow us to recommend Synthesit as a biologically active nutraceutical in addition to nutrition to improve immunity, general energy tone of the body.
Its biological activity in metabolic disorders was also mentioned in the lecture of Olga Oinotkinova, M.D., Professor, Honored Physician of the Russian Federation, at the scientific and practical conference "Age - Associated Diseases and Active Longevity" held on December 22, 2022 with the support of the Russian Professors' Meeting and the Bioethics Committee of the Commission for UNESCO in the Russian Federation.
As follows from the presented presentation, the nutraceutical Synthesit can be considered as additional functional nutrition in metabolic disorders.
We would like to thank Olga Oinotkinova, M.D., Professor, for the high professional evaluation of Synthesit supplement action.